BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38669000)

  • 1. Comparison of central diabetes insipidus (antidiuretic hormone deficiency) and stalk effect in patients with adamantinomatous and papillary craniopharyngioma.
    Feng Y; Zhong L
    Acta Neurol Belg; 2024 Apr; ():. PubMed ID: 38669000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of neuroendocrine dysfunction in patients with adamantinomatous and papillary craniopharyngiomas.
    Feng Y; Ni M; Wang YG; Zhong LY
    Exp Ther Med; 2019 Jan; 17(1):51-56. PubMed ID: 30651764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and factors influencing hypothalamic pituitary dysfunction in patients with craniopharyngioma.
    Guo Y; Pei L; Li Y; Li C; Gui S; Ni M; Liu P; Zhang Y; Zhong L
    Front Endocrinol (Lausanne); 2023; 14():1180591. PubMed ID: 37324266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Endocrine and Metabolic Comorbidities in a National Cohort of Patients with Craniopharyngioma.
    Jazbinšek S; Kolenc D; Bošnjak R; Faganel Kotnik B; Zadravec Zaletel L; Jenko Bizjan B; Vipotnik Vesnaver T; Battelino T; Janež A; Jensterle M; Kotnik P
    Horm Res Paediatr; 2020; 93(1):46-57. PubMed ID: 32460296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of histological subtype with risk of recurrence in craniopharyngioma patients: a systematic review and meta-analysis.
    Wu J; Wu X; Yang YQ; Ding H; Yang L; Bao YY; Zhou L; Yang CX; Hong T
    Neurosurg Rev; 2022 Feb; 45(1):139-150. PubMed ID: 34159471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing.
    He J; Zeng Z; Wang Y; Deng J; Tang X; Liu F; Huang J; Chen H; Liang R; Zan X; Liu Z; Tong A; Guo G; Xu J; Zhu X; Zhou L; Peng Y
    Mol Cancer; 2021 Dec; 20(1):168. PubMed ID: 34922552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative immunohistochemical expression of β-catenin, EGFR, ErbB2, and p63 in adamantinomatous and papillary craniopharyngiomas.
    Esheba GE; Hassan AA
    J Egypt Natl Canc Inst; 2015 Sep; 27(3):139-45. PubMed ID: 26198262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth patterns of craniopharyngiomas: clinical analysis of 226 patients.
    Pan J; Qi S; Liu Y; Lu Y; Peng J; Zhang X; Xu Y; Huang GL; Fan J
    J Neurosurg Pediatr; 2016 Apr; 17(4):418-33. PubMed ID: 26636252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngioma.
    Coy S; Rashid R; Lin JR; Du Z; Donson AM; Hankinson TC; Foreman NK; Manley PE; Kieran MW; Reardon DA; Sorger PK; Santagata S
    Neuro Oncol; 2018 Jul; 20(8):1101-1112. PubMed ID: 29509940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological Features of Craniopharyngioma: A 15-Year Study From a Tertiary Care Center in Pakistan.
    Haroon S; Afzal A; Zia S; Ali SJ; Zia F; Shamail F; Irfan M; Hashmi AA
    Cureus; 2021 Mar; 13(3):e14153. PubMed ID: 33936868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological and Prognostic Characterization of Craniopharyngioma Based on the Expression of TrkA, β-Catenin, Cell Cycle Markers, and BRAF V600E Mutation.
    Xu C; Ge S; Cheng J; Gao H; Zhang F; Han A
    Front Endocrinol (Lausanne); 2022; 13():859381. PubMed ID: 35707464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-resolution melting and immunohistochemical analysis efficiently detects mutually exclusive genetic alterations of adamantinomatous and papillary craniopharyngiomas.
    Yoshimoto K; Hatae R; Suzuki SO; Hata N; Kuga D; Akagi Y; Amemiya T; Sangatsuda Y; Mukae N; Mizoguchi M; Iwaki T; Iihara K
    Neuropathology; 2018 Feb; 38(1):3-10. PubMed ID: 28840946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemistry or Molecular Analysis: Which Method Is Better for Subtyping Craniopharyngioma?
    Fukuhara N; Iwata T; Inoshita N; Yoshimoto K; Kitagawa M; Fukuhara H; Tatsushima K; Yamaguchi-Okada M; Takeshita A; Ito J; Takeuchi Y; Yamada S; Nishioka H
    Endocr Pathol; 2021 Jun; 32(2):262-268. PubMed ID: 32965631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do craniopharyngioma molecular signatures correlate with clinical characteristics?
    Omay SB; Chen YN; Almeida JP; Ruiz-Treviño AS; Boockvar JA; Stieg PE; Greenfield JP; Souweidane MM; Kacker A; Pisapia DJ; Anand VK; Schwartz TH
    J Neurosurg; 2018 May; 128(5):1473-1478. PubMed ID: 28707994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtype-dependent difference of glucose transporter 1 and hexokinase II expression in craniopharyngioma: an immunohistochemical study.
    Mukada N; Tosaka M; Matsumura N; Yamaguchi R; Aihara M; Isoda K; Higuchi T; Tsushima Y; Yokoo H; Yoshimoto Y
    Sci Rep; 2021 Jan; 11(1):126. PubMed ID: 33420213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the treatment of Adamantinomatous craniopharyngioma: How to balance tumor control and quality of life in the current environment: a narrative review.
    Chen A; Ai M; Sun T
    Front Oncol; 2023; 13():1326595. PubMed ID: 38188294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of preventive use of vasopressin tannate on diabetes insipidus and serum sodium at the early postoperation of craniopharyngioma].
    Xiong T; Wanggou S; Li X; Liu Q; Jiang X; Peng Z; Yuan X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 41(10):1058-1063. PubMed ID: 27807328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Central diabetes insipidus after resection of sellar-suprasellar tumors: prevalence and predictors of manifestation].
    Badmaeva IN; Astafieva LI; Kalinin PL; Kadashev BA; Kutin MA
    Zh Vopr Neirokhir Im N N Burdenko; 2021; 85(6):111-118. PubMed ID: 34951768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of SRY-related HMG Box Transcription Factors (Sox) 2 and 9 in Craniopharyngioma Subtypes and Surrounding Brain Tissue.
    Thimsen V; John N; Buchfelder M; Flitsch J; Fahlbusch R; Stefanits H; Knosp E; Losa M; Buslei R; Hölsken A
    Sci Rep; 2017 Nov; 7(1):15856. PubMed ID: 29158570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papillary craniopharyngioma in a patient following resection of nonfunctioning pituitary adenoma: illustrative case.
    Park DJ; Mishra A; Golub D; Li JY; Black KS; Schulder M
    J Neurosurg Case Lessons; 2021 Jan; 1(2):CASE2063. PubMed ID: 35854932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.